Cover
Cover | 12 Months Ended | |
Jun. 06, 2024 | Dec. 31, 2024 | |
Cover [Abstract] | ||
Document Type | 8-K | |
Document Period End Date | Jun. 06, 2024 | |
Entity Registrant Name | KIORA PHARMACEUTICALS, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 98-0443284 | |
Entity File Number | 001-36672 | |
Entity Address, Address Line One | 332 Encinitas Blvd. | |
Entity Address, Address Line Two | Suite 102 | |
Entity Address, City or Town | Encinitas | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 92024 | |
City Area Code | 858 | |
Local Phone Number | 224-9600 | |
Written Communications | false | |
Soliciting Material | false | |
Pre-commencement Tender Offer | false | |
Pre-commencement Issuer Tender Offer | false | |
Title of 12(b) Security | Common Stock, $0.01 par value | |
Trading Symbol | KPRX | |
Security Exchange Name | NASDAQ | |
Entity Emerging Growth Company | false | |
Entity Central Index Key | 0001372514 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 |